Clinical trial
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
NCT00521274
Study timeline
Study start (unknown)2007-08-01Date precision: month
Registry last updated2016-03-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostatic Neoplasmsunresolved
Interventions
MVA 5T4BIOLOGICAL
DocetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
The Methodist Hospital Research Institutelead sponsor
Oxford BioMedicacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00521274 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.